This Week at FDA: A busy week on the Hill, VRBPAC’s June meeting bonanza, and more

This Week at FDA

This Week at FDAMichael Mezher

Biologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy